Skip to main content
. 2014 Nov 25;57(23):10192–10197. doi: 10.1021/jm501375c

Figure 1.

Figure 1

Structures 37 of reported GLP-1 PAMs and ago-PAMs. All known GLP-1 PAMs have noatble limitations in assessing the GLP-1 potentiation mechanism in the periphery and CNS.